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Abstract The gene family of serine protease inhibitors of
the Kazal type (SPINK) are functional and positional
candidate genes for celiac disease (CD). Our aim was to
assess the gut mucosal gene expression and genetic
association of SPINK1,- 2,- 4, and -5 in the Dutch CD
population. Gene expression was determined for all four
SPINK genes by quantitative reverse-transcription polymer-
ase chain reaction in duodenal biopsy samples from
untreated (n=15) and diet-treated patients (n=31) and
controls (n=16). Genetic association of the four SPINK
genes was tested within a total of 18 haplotype tagging
SNPs, one coding SNP, 310 patients, and 180 controls. The
SPINK4 study cohort was further expanded to include 479
CD cases and 540 controls. SPINK4 DNA sequence
analysis was performed on six members of a multigenera-
tion CD family to detect possible point mutations or
deletions. SPINK4 showed differential gene expression,
which was at its highest in untreated patients and dropped
sharply upon commencement of a gluten-free diet. Genetic
association tests for all four SPINK genes were negative,
including SPINK4 in the extended case/control cohort. No
SPINK4 mutations or deletions were observed in the
multigeneration CD family with linkage to chromosome
9p21-13 nor was the coding SNP disease-specific. SPINK4
exhibits CD pathology-related differential gene expression,
likely derived from altered goblet cell activity. All of the
four SPINK genes tested do not contribute to the genetic
risk for CD in the Dutch population.
Keywords SPINK genes.Celiac disease.Quantitative
reverse-transcriptionpolymerasechainreaction.Genetic
association
Introduction
Celiac disease (CD) is a chronic inflammatory condition of
the small intestine because of an immunological intolerance
for the food protein gluten. Patients have to adhere to a life-
long diet devoid of gluten to prevent the detrimental effects
of a prolonged nutrient and mineral deficiency (Green and
Jabri 2003). Susceptibility for CD is predominantly
determined by genetic factors, and the complex inheritance
patterns suggest the interaction of multiple genes (van Heel
et al. 2005). It is well established that the adaptive immune
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of CD. Th1 activation of CD4
+ T cells follows gluten-
peptide presentation by DQ2 or DQ8 molecules expressed
on antigen-presenting cells (Sollid 2002). The HLA-DQA
and -DQB gene variants coding for these molecules are the
major genetic determinants for CD susceptibility (Koning
et al. 2005). Recently, the importance of innate immunity in
CD pathogenesis was also underscored by the observation
of induced IL15 expression and NKT cell chemotaxis
through the MICA and NKG2D molecules (Hue et al.
2004; Meresse et al. 2004). However, no genetic contribu-
tion of the cognate genes has been demonstrated. The notion
of crosstalk between the adaptive and innate immune
systems is not limited to CD and gets much attention in
studies of the inflammatory process (Hoebe et al. 2004).
This raises the question whether some aspects of innate
immunity may contribute to the genetic susceptibility for
CD. The innate immune system uses a wide array of defense
mechanisms against the invasion of pathogens. These
encompass the expression of pattern recognition receptors,
release of antimicrobial molecules, and preservation of
epithelial barrier and tissue integrity by, e.g., serine protease
inhibitors (Kimbrell and Beutler 2001).
One branch of the family of serine protease inhibitors is
that of the Kazal type (SPINK) that originally consisted of
four members in humans (SPINK1, SPINK2, SPINK4, and
SPINK5). Recently, as part of a cluster of SPINK genes on
chromosome 5q32 that already included SPINK1 and
SPINK5, five new SPINK(-like) members were identified
that were located more distally: SPINK5L2, SPINK6,
SPINK5L3, SPINK7,a n dSPINK9, respectively (NCBI
Map Viewer, build 36.1). However, these new members
lack functional annotation and were therefore not included
in this study. SPINK family members 1, 2, and 4 have a
comparable size and structure coded for by 4 exons with a
single Kazal type serine protease inhibitor domain.
SPINK5, in contrast, contains 33 exons that encode 15
inhibitory domains. All four SPINK members are thought to
be involved in the protection against proteolytic degrada-
tion of epithelial and mucosal tissues, although their major
site of expression may differ. SPINK1 is expressed in the
pancreas and the gastrointestinal tract, and mutations in this
gene are reported in various forms of pancreatitis (Pfutzer
and Whitcomb 2001). SPINK2 (located on 4q12) is
expressed in the testis, epididymis, and seminal vesicle,
where its antimicrobial function may be involved in
protection of fertility (Rockett et al. 2004). SPINK4 was
originally isolated from pig intestine (Agerberth et al. 1989)
and is abundantly expressed in human and porcine goblet
cells in the crypts of Lieberkühn but was also found in
monocytes and in the central nervous system (Metsis et al.
1992; Norberg et al. 2003). SPINK5 is expressed in the
thymus, vaginal epithelium, Bartolin’s glands, oral mucosa,
tonsils, and the parathyroid glands (Magert et al. 1999).
Mutations in SPINK5 are responsible for the Netherton
syndrome, a lethal skin disorder characterized by ichthyo-
sis, hair shaft defects, atopy, skin barrier defects, and
recurrent bacterial infections (Bitoun et al. 2002). Mouse
models of the Netherton syndrome have shown enhanced
proteolysis of desmoglein 1 and filaggrin in SPINK5
mutants (Descargues et al. 2005; Hewett et al. 2005).
Moreover, SPINK5 has also been associated with asthma
and atopic dermatitis (Blumenthal 2005).
Interestingly, both SPINK1 and SPINK5 are located on
chromosome 5q32. This region contains the CELIAC2
susceptibility locus that emerged repeatedly in linkage
studies (Babron et al. 2003). Despite the fact that this
region is rich in candidate cytokine genes and intense
mapping efforts were made, no closely associated genes
were identified (Ryan et al. 2005). Likewise, SPINK4 is
located on chromosome 9p13.3 and resides within a linkage
region (9p21-13) where we previously identified a novel
CD locus that segregated within a four-generation Dutch
family (van Belzen et al. 2004). Taken together, the role of
SPINK genes in epithelial and mucosal protection and the
important genetic locations of SPINK1, SPINK4,a n d
SPINK5 prompted us to subject the four conventional
members of the SPINK family to gene expression and
genetic association analyses to ascertain their possible role
in CD pathogenesis.
Materials and methods
Patient material
Duodenal biopsy samples were collected by endoscopy as
part of a routine CD diagnostic procedure or to monitor the
response to a gluten-free diet in previously diagnosed
patients. All patients were classified using the Marsh
nomenclature according to the UEGW criteria (Report of
a working group of the United European Gastroenterology
Week in Amsterdam 2001). Two biopsy samples taken in
parallel to those used for histological examination were
pooled and used for determination of gene expression. In
total, 62 individuals were examined with quantitative
reverse transcription polymerase chain reaction (qRT-
PCR), of which 16 were normal controls, and 46 were
CD patients (Fig. 1). The patient group consisted of 15
untreated cases with villous atrophy (MIII) and 31 patients
treated with a gluten-free diet who were in various stages of
mucosal recovery: MII (crypt hyperplasia; n=11), MI
(lymphocyte infiltration; n=8), and M0 (complete remis-
sion; n=12). The biopsies of all participating patients were
reevaluated by an experienced pathologist, and only CD
patients with a proven original Marsh III lesion were
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Fig. 1 Results of qRT-PCR of
SPINK genes in normal controls
(NC) and CD patients, either
untreated (MIII) or on a gluten-
free diet (MII–M0). The Marsh
stages refer to the pathological
conditions of the mucosa, char-
acterized by atrophy of the villi
(MIII); hyperplastic crypts be-
tween the villi (MIII–MII); and
enhanced lymphocyte infiltration
(MIII–MII–MI). Stage M0 indi-
cates complete remission com-
parable to controls. The genes
tested were as follows: SPINK1
(a); SPINK2 (b); SPINK4
(c); and SPINK5 (d). Measure-
ments were made in triplicate, on
pools of separately prepared
cDNA samples. Expression data
were normalized to the normal
control pool.(e)R e l a t i v ee x p r e s -
sion of all four SPINK genes
with respect to SPINK2 in the
healthy duodenal mucosa. Note
the logarithmic scale here. The
GUSB gene was used as an
endogenous control in all tests.
Error bars indicate standard
deviations
Immunogenetics (2007) 59:349–357 351included in this study. The genetic association study on all
four SPINK genes was initially conducted on a cohort of
310 independent CD patients and 180 independent age- and
sex-matched controls, all of which were from Dutch
Caucasian decent. In a second stage, exclusively focused
on all SPINK4 SNPs, we added 360 controls to a total of
540. In case of three SPINK4 variants with suggestive P
values, the power of the study was further enhanced by
adding 169 extra CD cases to a total of 479. In parallel, we
also examined the SPINK4 gene in a previously described
four-generation Dutch CD family (van Belzen et al. 2004).
Six family members and a CEPH control were subjected to
DNA sequence analysis of the SPINK4 coding regions and
splice sites boundaries. Additionally, we performed
SPINK4 SNP haplotype analysis in this family. All patients
and family members that volunteered for this study signed
an informed consent. The study was approved by the
Medical Ethics Committee of the University Medical
Center Utrecht.
Expression study
The isolation of total RNA from biopsy samples and the
analysis of gene expression by real-time qRT-PCR on an
ABI Prism 7900HT was performed as described before
(Wapenaar et al. 2004). We used the commercially available
Assay-on-Demand test for SPINK1 (Hs00162154_m1),
SPINK2 (Hs00221653_m1), SPINK4 (Hs00205508_m1),
SPINK5 (Hs00199260), and the endogenous control gene
GUSB (PDAR 4326320E; Applied Biosystems, Foster
City, CA). All samples were tested in triplicate on pooled
cDNA samples representing each Marsh class. The results
were confirmed with cDNA from individual samples tested
in duplicate. Relative levels of gene expression were
obtained using the SDS2.1 software (Applied Biosystems).
Genetic association and data analysis
Haplotype tagging SNPs were selected for SPINK1, SPINK2,
SPINK4,a n dSPINK5 based on HapMap (Phase I) data using
Haploview (Barrett et al. 2005). For each haploblock
containing SNPs in high linkage disequilibrium, one or more
representative SNPs were selected that should capture the
genetic variation within that block. For the four SPINK genes
tested, this resulted in a set of 18 haplotype tagging SNPs
and one coding SNP (see Table 1 and Fig. 2). SNP assays
were obtained from Applied Biosystems and analyzed on an
ABI Prism 7900HT. Hardy–Weinberg Equilibrium (HWE)
Table 1 Allelic distribution of SPINK haplotype tagging SNPs in a Dutch CD case-control cohort
Cases (n=310) Controls (n=180)
Allele Allele counts Allele
frequency (%)
Allele counts Allele
frequency (%)
Gene
name
SNP i.d. Position* Minor/
major
Minor Major Minor Major Minor Major Minor Major χ
2 P
value
SPINK1 rs10515593 147,178,993 A/G 119 449 21 79 76 268 22.1 77.9 0.166 0.6834
SPINK1 rs3777125 147,184,010 C/G 228 336 40.4 59.6 150 200 42.9 57.1 0.527 0.4681
SPINK1 rs4705204 147,195,313 C/A 125 429 22.6 77.4 60 276 17.9 82.1 2.813 0.0935
SPINK1 rs891992 147,205,707 G/A 77 483 13.8 86.2 47 303 13.4 86.6 0.019 0.8906
SPINK2 rs10015630 57,520,070 A/G 216 328 39.7 60.3 136 216 38.6 61.4 0.102 0.7489
SPINK2 rs781542 57,528,232 G/A 220 390 36.1 63.9 123 221 35.8 64.2 0.009 0.9237
SPINK4 rs563353 33,206,428 G/C 120 472 20.3 79.7 67 279 19.4 80.6 0.112 0.7375
SPINK4 rs563512 33,206,484 G/A 50 556 8.3 91.7 36 310 10.4 89.6 1.243 0.2648
SPINK4 rs891671 33,222,271 G/T 70 540 11.5 88.5 52 304 14.6 85.4 1.998 0.1575
SPINK4 rs706107** 33,230,225 A/G 117 499 19 81 81 269 23.1 76.9 2.358 0.1246
SPINK4 rs706109 33,230,668 A/G 118 486 19.5 80.5 82 276 22.9 77.1 1.549 0.2133
SPINK4 rs706115 33,243,605 G/C 77 537 12.5 87.5 52 308 14.4 85.6 0.716 0.3975
SPINK5 rs3756688 147,422,972 G/A 232 380 37.9 62.1 135 221 37.9 62.1 0.000 0.9968
SPINK5 rs4472254 147,433,830 A/C 240 376 39 61 142 214 39.9 60.1 0.081 0.7757
SPINK5 rs4519913 147,452,004 G/A 279 331 45.7 54.3 168 192 46.7 53.3 0.079 0.7792
SPINK5 rs1422987 147,466,552 T/C 49 559 8.1 91.9 27 329 7.6 92.4 0.070 0.7917
SPINK5 rs3815740 147,471,386 G/A 38 574 6.2 93.8 21 337 5.9 94.1 0.047 0.8291
SPINK5 rs2052532 147,476,500 G/A 200 414 32.6 67.4 117 241 32.7 67.3 0.001 0.9723
SPINK5 rs3764930 147,485,309 G/A 199 413 32.5 67.5 117 243 32.5 67.5 0.000 0.9958
*Basepair position according to NCBI build 35.1
**Coding SNP, nonsynonymous change (Val7Ile)
352 Immunogenetics (2007) 59:349–357Fig. 2 Genomic organization of
the four SPINK genes. The
upper horizontal line indicates
exon locations (vertical bars)
and SNP positions (numbered
asterisks). The SNPs are
numbered for each gene con-
secutively as they appear in
Table 1. SPINK4 SNP no. 4
represents the nonsynonymous
(Val7Ile) coding SNP rs706107.
The arrow points indicate the
orientation of transcription. The
lower portion of the figure
shows the pairwise linkage-
disequilibrium structure between
indicated SNPs given by D′
statistics based on the European
population in the HapMap
database (Phase II). Darker red
intensities indicate higher
D′ values (numbers indicate
D’ value, whereas SNP pairs
without number have a D′=1)
Immunogenetics (2007) 59:349–357 353was evaluated separately in cases and controls for all SNPs
tested. Allele frequencies were compared between cases and
controls, and P values were obtained by χ
2 analysis.
DNA sequence analysis
DNA sequence analysis was performed on SPINK4 in six
members of a four-generation Dutch CD family and one
CEPH control (family, 1,331; individual, 2). Of these six
family members, four were affected (index 02, 08, 32, and
41) and carried the disease-linked haplotype, and two were
nonaffected (index 21 and 31) without this haplotype
(Fig. 3). All coding sequences of the SPINK4 gene were
PCR-amplified, including the intron–exon boundaries (for
primers and protocols, see supplementary data Table 1).
PCR products were examined on a 2% agarose gel and
purified with a Millipore Vacuum Manifold (Billerica,
MA). Samples were prepared with the BigDye terminator
cycle sequencing ready kit (Applied Biosystems) according
to the manufacturer’s protocol. PCR and sequencing
amplification were performed on a GeneAmp PCR system
9700 (Perkin Elmer, Foster City, CA). Sequences were run
on an ABI Prism 3730 analyzer (Applied Biosystems).
Analysis and sequence alignment was carried out with
Sequence Navigator (Applied Biosystems) and Vector NTI
(InforMax, Massachusetts) software packages.
Results
SPINK gene expression in the CD mucosa
The expression of all four conventional members of the
human SPINK family was determined by real-time qRT-
PCR on duodenal biopsy-derived cDNA pools from normal
controls and CD patients, either untreated or in various
stages of remission on a gluten-free diet. The results shown
in Fig. 1 indicate that only SPINK4 (Fig. 1c) is differen-
tially expressed, and that its transcriptional activity, which
is at its highest in Marsh III (20-fold compared to controls),
decreases sharply (fourfold) when patients improve and
make a transition to Marsh II. To preclude that the results
for SPINK4 might be biased by fortuitous differences in
Fig. 3 Pedigree of the Dutch
multigeneration CD family.
Only affected descendents are
depicted (10 out of 13 siblings
in the second generation were
affected). The grandparental
SPINK4 haplotypes that are
boxed and shaded are identical
to the grandmaternal at-risk
haplotype (noninformative). The
SNPs are ordered (top-to-bot-
tom) as they appear in Table 1.
Genotype numbers 1, 2, 3, and 4
refer to A, C, G, and T alleles,
respectively. Sequence analysis
was performed on family mem-
bers 02, 08, 21, 31, 32, and 41.
Family member index numbers
are indicated in bold
354 Immunogenetics (2007) 59:349–357individual expression levels within the generated pools, we
also examined the control and case samples each separately.
This did not change the observed drop in SPINK4
expression during tissue recovery (see supplementary
Fig. 1). Likewise, we performed the same analysis for the
other three SPINK genes without affecting the profile
already observed in the pools (results not shown). We also
examined the relative expression of the four SPINK genes
with respect to each other in the normal intestinal mucosa.
This showed that both SPINK1 and SPINK4 have the
highest expression, which is respectively 480-fold and 240-
fold higher compared to SPINK2, whereas SPINK5 is in the
same order of magnitude (fivefold) as SPINK2 (Fig. 1e). In
conclusion, only the SPINK4 gene appears to be differen-
tially regulated in the intestinal mucosa during recovery
from the gluten-evoked CD lesion. This observation
prompted us to examine whether SPINK4, or any of the
other SPINK genes, could also be causally related to the CD
pathogenesis.
Genetic association analysis of SPINK genes
We designed a haplotype tagging SNP strategy to capture
all genetic variation in SPINK1,- 2,- 4, and -5. An overview
of these four SPINK genes with their genomic organization,
linkage-disequilibrium structure, and the position of the
haplotype tagging SNPs used is depicted in Fig. 2. Initially,
these haplotype tagging SNPs were tested in 310 CD cases
and 180 controls (Table 1) and showed no significant
association for any of the haplotype tagging SNPs in the
four SPINK genes. Despite the initial negative result, we
decided to pursue SPINK4 further because it is expressed in
goblet cells (Metsis et al. 1992), displayed a CD pathology-
related differential expression in the intestinal mucosa, and
mapped within a CD linkage region (van Belzen et al.
2004). Initially, we expanded the control group with 360
samples to a total of 540 for all SPINK4 SNPs tested. As a
result, the Val7Ile coding variant rs706107 and its flanking
haplotype tagging SNPs rs891671 and rs706109 yielded
suggestive but nonsignificant P values of 0.0595, 0.0510,
and 0.1122, respectively (data not shown). To increase the
power of the study even further, we subsequently added
169 CD cases to a total of 479. The effect on the P values
of the three SNPs tested was such that they dropped below
the significance threshold (see Table 2). From this, we
conclude that the four SPINK genes tested do not
contribute to the genetic susceptibility in the Dutch CD
population.
SPINK4 sequence analysis in a multigeneration family
We have previously described a four-generation CD family
with an extraordinary high incidence of affected individuals
(see Fig. 3). The disease segregated with a grandmaternal
haplotype on chromosome 9p21-13 (van Belzen et al.
2004), a region that encompasses SPINK4. The apparent
dominant inheritance pattern could be caused by a mutation
that is rare in the general CD population but present with a
high phenotypic penetration in this specific family. To
assess if any functional variants of the SPINK4 gene were
present in this family, we sequenced all its exons and
intron–exon boundaries in six family members. However,
we did not observe mutations in any of the samples tested
(results not shown). Neither was the exon 1 coding SNP
rs706107 specific for affected individuals as all seven
individuals tested (including the CEPH control) carried the
most frequent GG genotype (Fig. 3). To exclude the
possibility of deletions in SPINK4 to be misinterpreted
from the sequence data as homozygous genotypes, we also
performed segregation analysis of the grandparental
SPINK4 haplotypes within the entire family but observed
no suspect inheritance pattern (Fig. 3). In conclusion, we
have found no evidence that SPINK4 is a candidate gene
for the chromosome 9p21-13 CD locus in the Dutch
population in general or in the multigeneration Dutch CD
family specifically.
Table 2 Allelic distribution of three selected SPINK4 SNPs in the extended Dutch CD case-control cohort
Cases (n=479) Controls (n=540)
Allele Allele counts Allele
frequency (%)
Allele counts Allele
frequency (%)
Gene
name
SNP i.d. Position* Minor/
major
Minor Major Minor Major Minor Major Minor Major χ
2 P
value
SPINK4 rs891671 33,222,271 G/T 126 814 13.4 86.6 158 904 14.9 85.1 0.889 0.3457
SPINK4 rs706107** 33,230,225 A/G 205 737 21.8 78.2 242 814 22.9 77.1 0.382 0.5365
SPINK4 rs706109 33,230,668 A/G 212 724 22.6 77.4 242 816 22.9 77.1 0.014 0.9053
*Basepair position according to NCBI build 35.1
**Coding SNP, nonsynonymous change (Val7Ile)
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Chronic inflammatory conditions and autoimmune disor-
ders are typically characterized by a deregulated adaptive
and innate immune system. The innate defense consists of
multiple components that include physical barriers, antimi-
crobial molecules, pattern recognition receptors, circulating
phagocytes, and the complement system (Hoebe et al.
2004). A breach of the epithelial barrier and loss of
microbial containment is often the first of a series of events
that trigger or sustain chronic inflammatory diseases
(Tlaskalova-Hogenova et al. 2004) as described, e.g., in
Crohn’s disease, atopic eczema, asthma, and psoriasis
(Schreiber et al. 2005). In CD, the gut–lumen separation is
undermined by dietary gluten that evokes a combined innate
and adaptive immune response (Londei et al. 2005). It is the
joined action of gluten peptides, environmental factors, and
genetic determinants that precipitates this enteropathy. The
human leukocyte antigen locus is the major genetic
contribution to the adaptive Th1 reaction (Koning et al.
2005). Recently, we identified MYO9B as a susceptibility
gene in the Dutch population that possibly has an effect on
epithelial barrier integrity (Monsuur et al. 2005). Several
other studies have underscored the involvement of innate
immunity in CD, however, without identification of
underlying causative gene variants (Londei et al. 2005).
Interestingly, it was also reported that the epithelial
glycocalyx and the bacterial composition in the CD gut is
distinct (Forsberg et al. 2004; Tjellstrom et al. 2005).
In search of genes that may have a primary contribution
to CD pathogenesis, we focused our attention to the SPINK
family of serine protease inhibitors that play an important
role in tissue preservation through the containment of
uncontrolled proteolysis and bacterial growth. In this study,
we demonstrated differential gene expression of mucosal
SPINK4 in CD. Crypt hyperplasia is a feature of the Marsh
III and Marsh II stages of CD, and the concomitant increase
in the number of goblet cells may contribute to the
increased SPINK4 expression. However, the observed sharp
decrease in gene expression sets in during the MIII/MII
transition, whereas crypt normalization is observed only
later at the MII/MI recovery phase. This suggests that
SPINK4 downregulation sets in soon after commencement
of the gluten-free diet. This SPINK4 differential expression
probably reflects altered goblet cell activity, but its
functional significance and regulatory mechanism in CD
pathology remains to be established.
The combination of functional relevance and mapping to
CD linkage intervals pointed to the SPINK family members
as attractive functional and positional candidate genes. We
have chosen a robust strategy for genetic association
testing based on haplotype tagging SNPs and linkage-
disequilibrium structure of the SPINK loci applied to a
considerably sized Dutch case-control cohort. With our
study design, we had 75% power to confirm association
with SPINK1,- 2,a n d- 5 (relative risk 2.0; allele frequency
0.1–0.45; 95% confidence interval), whereas this was even
95% (RR 2.0) and 80% (RR 1.6) for SPINK4.T h e s e
power estimates reflect a Type I error rate of 0.05, which is
appropriate for testing a previously reported result. Initial
detection of a new genetic association would require much
more stringent criteria to assure reproducibility, and power
would be correspondingly less.
In parallel, we examined the extended Dutch CD family
for variants and deletions in SPINK4. We hypothesized that
a specific SPINK4 mutation, although rare in the general
population, could have a dramatic impact on mucus
composition, bacterial containment, and gluten sensitivity,
thereby explaining the apparent dominant and high pene-
tration inheritance pattern in our extended CD family. With
both approaches, we were not able to establish a genetic
involvement of the SPINK genes tested. However, we
cannot completely rule out the possibility of a rare
noncoding mutation in SPINK4 (outside the splice donor
and acceptor regions) that might specifically segregate in
this atypical CD family, characterized by an exceptional
high prevalence of affected members.
Despite this negative result in the Dutch CD population,
we cannot formally rule out the possibility of genetic
contribution of SPINK genes to CD in other European
populations like the Italian in whom, unlike the Dutch (van
Belzen et al. 2003), chromosome 5q linkage was estab-
lished (Greco et al. 1998; Percopo et al. 2003). Genuine
population heterogeneity has been reported before, e.g.,
between CARD15/NOD2 and Crohn’s disease (Lesage et al.
2002; Croucher et al. 2003) and between SPINK5 and
asthma (Blumenthal 2005; Jongepier et al. 2005). The new
SPINK members on chromosome 5q (SPINK5L2, SPINK6,
SPINK5L3, SPINK7, and SPINK9) were not part of this
study. Currently, no functional annotation is available for
these genes that are located near SPINK1 and SPINK5 in a
chromosomal region that appears to have been subjected
to gene duplication during evolution. Therefore, we cannot
exclude their possible involvement in CD or any other
inflammatory disorder.
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